Targeting Interleukin-6 for Treatment of CKD and Cardiovascular Disease.

Tuttle KR, Cherney DZ, Pecoits-Filho R, Pirro M, Yau K, Sahay M

Open source

DOI
10.1016/j.ekir.2026.106712
Published
2026 Oct
Container
Kidney international reports
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ekir.2026.106712,
  title = {Targeting Interleukin-6 for Treatment of CKD and Cardiovascular Disease.},
  author = {Tuttle KR and Cherney DZ and Pecoits-Filho R and Pirro M and Yau K and Sahay M},
  year = {2026},
  journal = {Kidney international reports},
  doi = {10.1016/j.ekir.2026.106712},
  url = {https://doi.org/10.1016/j.ekir.2026.106712}
}

RIS

TY  - JOUR
TI  - Targeting Interleukin-6 for Treatment of CKD and Cardiovascular Disease.
AU  - Tuttle KR
AU  - Cherney DZ
AU  - Pecoits-Filho R
AU  - Pirro M
AU  - Yau K
AU  - Sahay M
PY  - 2026
JO  - Kidney international reports
DO  - 10.1016/j.ekir.2026.106712
UR  - https://doi.org/10.1016/j.ekir.2026.106712
ER  - 

APA

KR, T., DZ, C., R, P., M, P., K, Y., & M, S. (2026). Targeting Interleukin-6 for Treatment of CKD and Cardiovascular Disease.. Kidney international reports. https://doi.org/10.1016/j.ekir.2026.106712

Source records